In summary, our work has demonstrated that METTL3 promoted colorectal cancer progression through upregulating JAK1 and STAT3 expression in m6A-dependent and -independent manners, contributing to the activation of the p-STAT3 signaling pathway. Here, METTL3 is linked to colorectal cancer.